Hikma Pharmaceuticals PLC (HKMPY)

USD 48.77

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 4.68 Billion 4.47 Billion 4.37 Billion 4.13 Billion 3.93 Billion 3.49 Billion
Total Current Assets 2.1 Billion 1.99 Billion 2.09 Billion 1.92 Billion 1.84 Billion 1.66 Billion
Cash And Short Term Investments 205 Million 270 Million 426 Million 323 Million 442 Million 297 Million
Cash and Cash Equivalents 205 Million 270 Million 426 Million 323 Million 442 Million 276 Million
Short Term Investments 103 Million 22 Million 24 Million 24 Million 23 Million 21 Million
Net Receivables 884 Million 843 Million 876 Million 796 Million 799 Million 825 Million
Inventory 891 Million 776 Million 695 Million 757 Million 568 Million 528 Million
Other Current Assets 120 Million 110 Million 97 Million 46 Million 39 Million 18 Million
Total Non-Current Assets 2.58 Billion 2.47 Billion 2.27 Billion 2.21 Billion 2.08 Billion 1.82 Billion
Net PPE 1.14 Billion 1.08 Billion 1.14 Billion 1.06 Billion 962 Million 870 Million
Good Will And Intangible Assets 1.1 Billion 1.12 Billion 892 Million 876 Million 834 Million 766 Million
Good Will 388 Million 389 Million 285 Million 289 Million 282 Million 279 Million
Intangible Assets 712 Million 735 Million 607 Million 587 Million 552 Million 487 Million
Long-Term Investments 10 Million 53 Million 33 Million 24 Million 20 Million 17 Million
Tax Assets 226 Million 192 Million 183 Million 221 Million 243 Million 125 Million
Other Non Current Assets 103 Million 22 Million 24 Million 24 Million 23 Million 51 Million
Other Assets - - - - - -
Total Liabilities 2.47 Billion 2.32 Billion 1.9 Billion 1.98 Billion 1.8 Billion 1.8 Billion
Total Current Liabilities 1.33 Billion 1.07 Billion 1.01 Billion 1.02 Billion 1.47 Billion 893 Million
Account Payables 568 Million 291 Million 262 Million 470 Million 473 Million 263 Million
Tax Payables 74 Million 73 Million 57 Million 72 Million 61 Million 65 Million
Short Term Debt 161 Million 148 Million 121 Million 168 Million 578 Million 75 Million
Deferred Revenue 226 Million 193 Million 294 Million 100 Million 105 Million 65 Million
Other Current Liabilities 384 Million 445 Million 339 Million 290 Million 315 Million 490 Million
Total Non Current Liabilities 1.13 Billion 1.24 Billion 889 Million 959 Million 330 Million 907 Million
Long-Term Debt 1.03 Billion 1.13 Billion 725 Million 764 Million 107 Million 562 Million
Deferred Revenue Non Current 7 Million - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 70 Million 92 Million 140 Million 164 Million 203 Million 329 Million
Other Liabilities - - - - - -
Total Equity 2.2 Billion 2.14 Billion 2.46 Billion 2.14 Billion 2.12 Billion 1.69 Billion
Stock Holders Equity 2.19 Billion 2.13 Billion 2.45 Billion 2.13 Billion 2.11 Billion 1.68 Billion
Common Stock 40 Million 40 Million 42 Million 41 Million 41 Million 40 Million
Retained Earnings 2.15 Billion 2.09 Billion 2.18 Billion 1.89 Billion 1.97 Billion 1.58 Billion
Accumulated other comprehensive income -282 Million -279 Million -60 Million -80 Million -178 Million -216 Million
Common Stock Equity 2.19 Billion 2.13 Billion 2.45 Billion 2.13 Billion 2.11 Billion 1.68 Billion
Capital Lease Obligation 66 Million 70 Million 83 Million 82 Million 68 Million 24 Million
Total Investments 113 Million 75 Million 57 Million 48 Million 43 Million 68 Million
Total Debt 1.19 Billion 1.28 Billion 846 Million 932 Million 685 Million 637 Million
Net Debt 986 Million 1.01 Billion 420 Million 609 Million 243 Million 361 Million

Balance Sheet Charts